Under the new rules, cannabis would be reclassified as a schedule III drug, meaning any cannabis-based medications would probably require FDA approval and a doctor's prescription.
Grinspoon thinks rescheduling could make it easier to study medical cannabis by easing stigma as well as legal restrictions. People on both sides of the debate are going to be sort of forced to contend with reality.
Grinspoon is particularly keen to see research on whether cannabis could actually fight diseases. He says, I'm interested to know if cannabis can help modify the course of diseases versus just treat the symptoms.
Collection
[
|
...
]